Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
01/2003
01/30/2003WO2002047679A8 Nonpeptide agonists and antagonists of vasopressin receptors
01/30/2003US20030023095 Reacting 4-nitro-N- methylaniline and carbyl sulphate in presecne of a nitrile-substituted organic hydrocarbon, an ether of polyhydric alcohols or a cyclic ether
01/30/2003US20030023016 Cross-linkable bi-sulphonyl derivatives and their uses for preparing ion-exchanging membranes
01/30/2003US20030022934 For therapy and prophylaxis of pain and/or neurodegenerative disorders
01/30/2003US20030022893 Hydroxamic and carboxylic acid derivatives
01/30/2003US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula
01/30/2003US20030022882 Forming the 2-amino-2,4,4-trimethylpentane salt of clavulanic acid and converting that salt into a pharmaceutically acceptable salt of clavulanic acid, such as potassium clavulanate
01/30/2003US20030022114 Method for preparing an acid salt of p-phenylenediamine-type photographic color developers
01/30/2003CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
01/30/2003CA2452322A1 Inhibitors of the ice/ced-3 family of cysteine proteases
01/29/2003EP1279662A1 Process for preparing phenylcyclohexan-1-ylcarboxylic acids
01/29/2003EP1278734A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
01/29/2003EP1278718A1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
01/29/2003EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
01/29/2003EP0973735B1 Polyaromatic antiviral compositions
01/28/2003US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/28/2003US6511989 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death
01/28/2003US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia
01/27/2003WO2002010127A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
01/27/2003CA2417427A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
01/24/2003WO2002010145A1 Urethane derivatives
01/24/2003CA2417268A1 Urethane derivatives
01/23/2003WO2003006628A2 Nad synthetase inhibitors and uses thereof
01/23/2003WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003WO2002072537A3 Water- and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
01/23/2003WO2002008177A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
01/23/2003US20030018016 Cell adhesion inhibitors
01/23/2003US20030017948 For herbicides
01/23/2003US20030017426 Method for purifying free-base p-phenylenediamine-type photographic color developers
01/23/2003CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003CA2418173A1 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
01/22/2003EP1277729A1 Ppar (gamma) modulators
01/22/2003EP1276717A2 Inhibitors of the ice/ced-3 family of cysteine proteases
01/22/2003EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide
01/21/2003US6509500 Reacting an amine with acid chloride
01/21/2003US6509472 For use in enantioselective reduction of prochiral ketones to chiral secondary alcohols
01/21/2003US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids
01/16/2003WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma
01/16/2003WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3
01/16/2003WO2003004458A1 New compounds
01/16/2003WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
01/16/2003WO2002046129A3 Inhibitors of histone deacetylase
01/16/2003WO2001062705A3 Aminoalcohol derivatives
01/16/2003US20030013915 Method for preparing fluorosulfonyl imide monomer
01/16/2003US20030013910 Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives
01/16/2003US20030013760 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
01/16/2003US20030013751 Viricides; enzyme inhibitors
01/16/2003US20030013725 Amino acid derivatives
01/16/2003US20030013714 Sleep disorders; eating disorders; sexual disorders; hypotensive agents
01/16/2003US20030013124 Solid support for use in monitoring hybridization reactions
01/16/2003CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3
01/15/2003EP1275641A2 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
01/15/2003EP1275389A1 Compositions containing C7 Taxanes
01/15/2003EP1274678A1 Novel alpha-sulfin- and alpha-sulfonamido acid amides
01/15/2003EP1274675A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
01/15/2003EP1274415A2 Il-8 receptor antagonists
01/15/2003EP1274353A1 A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container
01/15/2003EP1060200B1 Substantially fluorinated ionomers
01/15/2003CN1391565A Benzophenones as inhibitors of reverse transcriptase
01/15/2003CN1391555A Benzamides and related inhibitors of factor Xa
01/15/2003CN1391554A Method for preparing dimetal sulfonyl amide salts
01/15/2003CN1391469A Npyy5拮抗剂 Npyy5 antagonist
01/14/2003US6506937 Used as antiarrhythmics
01/14/2003US6506936 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
01/14/2003US6506799 Treating or preventing a cardiovascular disease in a patient, comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of 6-(6-hydroxy-5,5-dimethylhexyloxy)-2,2-dimethyl-hexan-1-ol and
01/14/2003US6506798 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
01/14/2003US6506786 HIV protease inhibitors based on amino acid derivatives
01/14/2003US6506733 Compounds and compositions as protease inhibitors
01/14/2003US6506701 Polymer-supported quenching reagent covalently reacts with unreacted starting materials
01/14/2003US6506517 Surface modified carbonaceous materials
01/09/2003WO2003003115A1 Method for purifying free-base p-phenylenediamine-type photographic color developers
01/09/2003WO2003002525A1 NOVEL N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-$G(a)-SULFIN- AND $G(a)-SULFONAMINO ACID AMIDES
01/09/2003WO2003002519A1 Phenol derivatives and their use in medicaments
01/09/2003WO2003002157A1 Solid-phase nucleophilic fluorination
01/09/2003US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
01/09/2003US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives
01/09/2003US20030008849 For therapy of diseases mediated by TNF- alpha , such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss
01/09/2003CA2450708A1 Novel n-bisaryl- and n-aryl-cycloalkylidenyl .alpha.-sulfin- and .alpha.-sulfonamino acid amides
01/08/2003EP1272461A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
01/08/2003EP1272460A1 Novel alpha-sulfin- and alpha-sulfonamino acid amide derivatives
01/08/2003EP1272459A1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
01/08/2003EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors
01/08/2003EP1272175A2 Il-8 receptor antagonists
01/08/2003EP1123276B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
01/08/2003CN1390206A Inhibitors of factor Xa
01/08/2003CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
01/07/2003US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents
01/07/2003US6503949 Glucagon antagonists/inverse agonists
01/07/2003CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease
01/03/2003WO2003000654A1 Valproyltaurinamide derivatives as anticonvulsant and cns active agents
01/03/2003WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments
01/03/2003WO2002038850A3 Alkylated fluorochemical oligomers and use thereof in the treatment of fibrous substrates
01/03/2003CA2451625A1 Substituted n-acyl-aniline derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
01/02/2003US20030004196 Antiinflamamtory agents; autoimmune disease
01/02/2003US20030004151 Cyclic derivatives as modulators of chemokine receptor activity
01/02/2003US20030001130 Water-and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
01/02/2003EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives
01/02/2003EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
01/02/2003EP1268414A1 Ceramide derivatives and method of use
01/02/2003EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 177